Publications by authors named "Yarden Aharoni-Tevet"
Article Synopsis
- - CD19 CAR-T cells have shown long-lasting remission in patients with hard-to-treat B-cell cancers, but many eventually relapse, prompting research into ways to enhance their effectiveness.
- - A study found that CAR-T cells leading to complete responses had higher mitochondrial function, suggesting that boosting cellular metabolism could improve their efficacy in treating leukemia.
- - By switching the growth medium from glucose to galactose, researchers increased mitochondrial activity in CAR-T cells, leading to better performance in lab tests and improved leukemia-free survival in mouse models compared to traditional glucose-based methods.
